Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
biotech
startups
3
×
boston blog main
boston top stories
deals
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
vc
acetylon pharmaceuticals
ambys medicines
artificial intelligence
azacitidine
beta-thalassemia
boston
cell therapy
constellation pharmaceuticals
dacogen
decitabine
dna
epigenetics
epizyme
farydak
flagship pioneering
fulcrum therapeutics
gene therapy
genentech
health
holger willenbring
insulated genomic domains
ipo
jeffrey tong
juan carlos izpisua belmonte
kaleido biosciences
keith dionne
liver disease
What
biotech
3
×
medicines
3
×
new
3
×
called
developing
drugs
research
startup
aiming
aims
algorithms
ambys
approach
based
batch
big
bottlenecks
clinical
combinator’s
control
cost
deadly
deal
debuted
debuts
development
diseases
dollars
drug
epigenetic
epigenetics
field
fix
flagship’s
formed
future
labs
latest
launch
learning
Language
unset
Current search:
new
×
startups
×
medicines
×
biotech
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@techcrunch.com
6 years ago
Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks